Medical Debt Relief: CFPB Finalizes Landmark Credit Reporting Rule

CFPB Finalizes Rule to Remove Medical Bills from Credit Reports

The Consumer Financial Protection Bureau (CFPB) has taken a monumental step by finalizing a rule to eliminate medical bills from credit reports. This action is expected to transform the financial landscape for millions of Americans by removing unfair barriers to credit access caused by medical debt.

What the Rule Does:

  1. Removes Medical Debt from Credit Reports:
    • Medical bills will no longer appear on consumer credit reports, ensuring that past-due medical expenses do not impact credit scores.
    • This change will empower consumers to qualify for financial products like mortgages, car loans, and credit cards without the shadow of medical debt.
  2. Ensures Fair Lending Practices:
    • Lenders can no longer use medical debt as a factor in determining creditworthiness.
    • The CFPB emphasizes that medical debt is often an unreliable indicator of financial responsibility, as it frequently arises from emergencies or billing errors.
  3. Aligns with Consumer Protections:
    • This rule builds on previous actions by the CFPB, including efforts to address inaccuracies in credit reporting and ensure fair treatment of consumers.
    • Medical debt collections often stem from disputes over insurance coverage or billing errors, making their inclusion on credit reports particularly problematic.

Why This Matters:

Medical debt has been a significant hurdle for millions, disproportionately affecting those facing unexpected health crises or billing inaccuracies. The CFPB’s research has shown that the presence of medical debt on credit reports can unfairly penalize consumers, even when the debt is small or being disputed. By eliminating medical bills from credit reports, the CFPB aims to provide relief to consumers and promote fairer credit evaluations.

Implementation Details:

The rule, which amends Regulation V under the Fair Credit Reporting Act (FCRA), will take effect starting March 17, 2025. This timeline allows for a smooth transition while ensuring compliance across financial institutions. It also aligns with broader federal efforts to alleviate the burden of medical debt on American households.

A Broader Perspective:

This initiative is part of the CFPB’s ongoing commitment to protect consumers from financial harm and ensure equitable access to credit. By addressing the systemic issues associated with medical debt, the agency is helping millions of Americans achieve financial stability. Additionally, the CFPB’s efforts highlight the need for transparency and accuracy in credit reporting practices.

For more details, read the official CFPB announcement here.

NeueHealth Merger Investigation (NEUE)

NeueHealth Stock – Is the Proposed Acquisition of NeueHealth By An Affiliate of Its Controlling Shareholder Fair to NEUE Shareholders? –  

Kehoe Law Firm, P.C. is investigating potential claims on behalf of investors of NeueHealth, Inc. (“NeueHealth”) (NYSE: NEUE) regarding the adequacy and fairness of the proposed acquisition by NeueHealth’s controlling shareholder, New Enterprise Associates (“NEA”).

Under the terms of the proposed all-cash transaction, NEA’s affiliate would acquire NeueHealth for $7.33 per share. NEA already owns 53.8% of NeueHealth, raising significant concerns about the fairness and independence of the process undertaken by NeueHealth’s Board of Directors.

INVESTORS OF NEUEHEALTH STOCK CAN CLICK HERE OR EMAIL [email protected] TO CONTACT KEHOE LAW FIRM, P.C. TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

KEY INVESTIGATIVE CONCERNS:

Inadequate Deal Protections:  Although NeueHealth’s Board formed a special committee, it does not appear to have implemented customary safeguards, such as requiring a majority of the minority vote to approve the transaction.

Below-Market Valuation: The offer price of $7.33 per share is substantially below NeueHealth’s 52-week average price of $16.59 and its 52-week high of $31.00, suggesting an undervaluation that does not reflect NeueHealth’s true potential.

Conflict of Interest: Was the transaction the result of a flawed process driven by a conflicted board, heavily influenced by the controlling shareholder?

CURRENT SHAREHOLDERS OF NEUEHEALTH STOCK INTERESTED IN SEEKING ADDITIONAL INFORMATION ABOUT THE MERGER INVESTIGATION AND POTENTIAL LEGAL CLAIMS CAN CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected].

Consumer Financial Protection Bureau Has Sued the Operator of Zelle and Three of the Nation’s Largest Banks

CFPB Sues JPMorgan Chase, Bank of America, and Wells Fargo

On December 20, 2024, the Consumer Financial Protection Bureau (“CFPB”) announced that it has sued the operator of Zelle and three of the nation’s largest banks for failing to protect consumers from widespread fraud on America’s most widely available peer-to-peer payment network.

Early Warning Services, which operates Zelle, along with three of its owner banks—Bank of America, JPMorgan Chase, and Wells Fargo—rushed the network to market to compete against growing payment apps such as Venmo and CashApp, without implementing effective consumer safeguards.

Customers of the three banks named in the lawsuit have lost more than $870 million over the network’s seven-year existence due to these failures. The CFPB’s lawsuit describes how hundreds of thousands of consumers filed fraud complaints and were largely denied assistance, with some being told to contact the fraudsters directly to recover their money.

According to the CFPB, Bank of America, JPMorgan Chase, and Wells Fargo also allegedly failed to properly investigate complaints or provide consumers with legally required reimbursement for fraud and errors.

The CFPB is seeking to stop the alleged unlawful practices, secure redress and penalties, and obtain other relief.

For additional details, please CLICK HERE. 

Source: Consumerfinance.gov

CFPB Announces Major Actions to Protect Consumers From Illegal Credit Card Practices

CFPB Takes Action on Bait-and-Switch Credit Card Rewards Tactics

CFPB warns companies against illegal devaluation of rewards and other unlawful practices, highlights issues with retail credit cards, and launches a tool to help find cards with lower rates

The Consumer Financial Protection Bureau (“CFPB”) has announced major actions to protect consumers from illegal credit card practices and help people save money on interest and fees. In a circular to other law enforcement agencies, the CFPB warned that some credit card companies operating rewards programs may be breaking the law, including by illegally devaluing rewards points and airline miles. The CFPB also published new research finding that retail credit cards—which typically offer store-specific rewards and loyalty programs—charge significantly higher interest rates than traditional cards.

The CFPB further launched a new tool, Explore Credit Cards, to help consumers find the best credit card rates across both rewards cards and traditional cards. This first-of-its-kind tool enables consumers to compare more than 500 credit cards using unbiased, comprehensive data.

CFPB Moves to Stop Credit Card Rewards Program Schemes

The circular released by the CFPB addresses practices in credit card rewards programs, which companies increasingly use to encourage consumers to apply for and use specific cards. Since 2019, more than 90 percent of general-purpose credit card spending occurred on rewards cards. In today’s marketplace, credit card issuers often promise cash, points, and miles sign-up bonuses to consumers, as well as rewards for certain types of spending. Consumers have reported to the CFPB that these rewards can be difficult to redeem or are sometimes devalued by policy changes by partners.

The CFPB circular warns that companies may violate federal law when they:

  • Devalue earned rewards: Consumers make decisions on whether to open or use a credit card based on the value of card benefits and rewards conveyed by a company’s advertising and other communications. If the company later deflates the value of a customer’s accrued awards, this may be an unfair or deceptive practice resembling a bait-and-switch scheme.
  • Hide the conditions for earning or keeping rewards: Fine print disclaimers or vague terms buried in a contract may unlawfully conflict with prominent promotional language advertising the rewards consumers can earn. Companies may also illegally rely on fine print to cancel valuable rewards that consumers have already earned. If consumers’ receipt of rewards is revoked, canceled, or prevented based on buried or vague conditions, that may be an unfair or deceptive act or practice.
  • Fail to deliver promised benefits: Companies operating rewards programs are responsible for ensuring consumers can redeem the rewards they have earned, including coordinating with merchant partners and vendors. If system failures result in consumers losing points when attempting to redeem, this may be considered an unfair or deceptive practice.

Source: ConsumerFinance.gov

Dave & Buster’s Securities Investigation (PLAY)

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Dave & Buster’s Entertainment Inc. (“Dave & Buster’s”) (NASDAQ: PLAY).

INVESTORS OF DAVE & BUSTER’S STOCK WITH FINANCIAL LOSSES CAN CLICK HERE OR EMAIL [email protected] TO CONTACT KEHOE LAW FIRM, P.C. TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

On December 10, 2024, Dave & Buster’s reported that “Chris Morris, the Company’s Chief Executive Officer (“CEO”), has tendered his resignation as CEO and Director to pursue other interests. The Board has been working with Heidrick & Struggles, a global executive search firm, for the last few months to assist in identifying the Company’s next permanent CEO and has already started meeting potential candidates.”

On this news, Dave & Buster’s stock dropped more than 14% intraday on December 11, 2024.

INVESTORS OF DAVE & BUSTER’S STOCK WITH FINANCIAL LOSSES ALSO CAN CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT.801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE DAVE & BUSTER’S SECURITIES CLASS ACTION INVESTIGATION AND POTENTIAL LEGAL CLAIMS.